Core Insights - Biotricity Inc. continues to demonstrate strong financial performance with positive EBITDA and ongoing revenue growth [1] - The company is set to host its Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11, 2026, at 4:30 PM ET [2] - Biotricity is focused on transforming the healthcare industry through innovative remote monitoring and diagnostic solutions [1][3] Financial Performance - The company has achieved a positive EBITDA, indicating improved operational efficiency and margin strength [1] - Continued growth in financial performance is highlighted, although specific revenue figures are not disclosed [1] Business Update Call - The upcoming call will feature remarks from Biotricity's Founder and CEO, Dr. Waqaas Al-Siddiq, and CFO, John Ayanoglou, followed by a Q&A session for investors [1][2] - Investors can access the call via a toll-free number or through a webcast, with a replay available approximately three hours after the live event [2][3] Company Overview - Biotricity is dedicated to bridging gaps in remote monitoring and chronic care management, providing trusted solutions for preventive and personal care [3] - The company develops comprehensive remote health monitoring solutions for both medical and consumer markets [3]
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th